Comparing the effectiveness of continuous subcutaneous insulin infusion with multiple daily insulin injection for patients with type 1 diabetes mellitus evaluated by retrospective continuous glucose monitoring: A real-world data analysis
ObjectiveRegarding the effects and practical application of insulin pumps on patients with type 1 diabetes mellitus (T1DM), the real-world evidence is limited especially concerning the incidence of hypoglycemia. This study aimed to compare the efficacy of continuous subcutaneous insulin infusion (CS...
Saved in:
Main Authors: | Guo Keyu (Author), Li Jiaqi (Author), Zhang Liyin (Author), Ye Jianan (Author), Fan Li (Author), Ding Zhiyi (Author), Zhou Qin (Author), Li Xia (Author), Yang Lin (Author), Zhou Zhiguang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Transient Neonatal Diabetes Mellitus Managed with Continuous Subcutaneous Insulin Infusion (CSII) and Continuous Glucose Monitoring
by: Min Soo Kim, et al.
Published: (2021) -
Real-time continuous glucose monitoring-guided glucose management in inpatients with diabetes receiving short-term continuous subcutaneous insulin infusion: a randomized clinical trialResearch in context
by: Yaxin Wang, et al.
Published: (2024) -
Continuous Subcutaneous Insulin Infusion (CSII) versus Multiple Daily Injections (MDI): Impact on Glycemic Control and Pregnancy Outcomes in Gestational Diabetes
by: Xiling Shi, et al.
Published: (2024) -
Parents' experiences on the combined use of continuous subcutaneous insulin infusion and real‐time continuous glucose monitoring to manage Type 1 diabetes in their children: A systematic review and meta‐synthesis of qualitative studies
by: Xiuwen Luo, et al.
Published: (2022) -
Treatment satisfaction and quality of life of adolescents with T1DM using continuous subcutaneous insulin infusion
by: Lígia Lima, et al.
Published: (2022)